Partner

601 Lexington Avenue
New York, NY 10022

+1 212 277 4077

Local Litigation Star

National Practice Area Star

Top 250 Women in Litigation


Practice area:

Securities


Meredith Kotler is co-head of the securities and shareholder litigation practice at Freshfields, where she specializes in high-stakes litigation, including securities, M&A, and shareholder disputes. She represents multi-national companies, financial institutions, and their boards and management in significant securities class actions, having secured important dismissals in both federal and state courts. As major M&A transactions and board-level controversies continue to receive scrutiny, Meredith has defended companies, their management and boards, and their financial advisors in litigation relating to dozens of transactions with a cumulative value of over $100 billion in the last six years alone. She has also played a leading role in many matters raising novel corporate governance issues, including the corporate control battle between National Amusements, Inc. and CBS Corporation, for which she was named “Litigator of the Week” by The American Lawyer for her successful representation of NAI and the Redstones. 


From 1998 to 2004, Meredith served as an Assistant US Attorney in the Southern District of New York, including as Deputy Chief Appellate Attorney. She often speaks on litigation panels, and her writings on the latest developments in Delaware courts and securities litigation have been published in the Harvard Law School Forum on Corporate Governance and other outlets.


Meredith received a J.D. degree, cum laude, from Harvard Law School in 1996 and an undergraduate degree, summa cum laude, from Princeton University in 1992. In 1997,

she clerked for the Honorable Barbara S. Jones of the U.S. District Court for the Southern District of New York. 


In addition to her recognition by Benchmark Litigation as a “National Practice Area Star” and “Local Litigation Star” for Securities Litigation, Meredith is ranked by Chambers for Securities Litigation, and is recognized by The Legal 500 as a “Hall of Fame” Lawyer for M&A Litigation. 

 

Meredith’s recent representations include:

  • 3M Company, several officers and directors in securities class action and related shareholder derivative suits based on alleged failure to disclose contingent environmental liabilities.
  • AstraZeneca, its CEO, and several other executives in securities class action challenging statements regarding clinical trial of its COVID-19 vaccine.
  • Tyson Foods and its officers and directors in securities class action alleging failure to disclose purportedly insufficient COVID-19 safety protocols at Tyson facilities.
  • Energy Recovery in securities class action filed in connection with termination of licensing agreement
  • Apyx Medical and CEO in securities class action based on FDA denial of drug approval.
  • Board of Directors of Ambac Financial in stockholder challenge to director compensation.
  • SourceHOV in appeal to Delaware Supreme Court after adverse judgment in appraisal action before Delaware Chancery Court.
  • Special Committee of Board of Directors of Emerald Holding in Delaware Chancery shareholder litigation challenging $400 million PIPE by controlling stockholder Onex Corporation.

 

Updated Sep 2021